NasdaqCM - Nasdaq Real Time Price • USD
Brainstorm Cell Therapeutics Inc. (BCLI)
At close: 4:00 PM EDT
After hours: 6:11 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Expense
21,439.0000
24,822.0000
24,539.0000
31,684.0000
Operating Income
-21,439.0000
-24,822.0000
-24,539.0000
-31,684.0000
Net Non Operating Interest Income Expense
-447.0000
545.0000
82.0000
-127.0000
Other Income Expense
4,694.0000
--
--
--
Pretax Income
-17,192.0000
-24,277.0000
-24,457.0000
-31,811.0000
Net Income Common Stockholders
-17,192.0000
-24,277.0000
-24,457.0000
-31,811.0000
Diluted NI Available to Com Stockholders
-17,192.0000
-24,277.0000
-24,457.0000
-31,811.0000
Basic EPS
-0.40
-0.66
-0.68
-1.07
Diluted EPS
-0.40
-0.66
-0.68
-1.07
Basic Average Shares
43,075.9380
36,509.0600
36,181.7530
29,848.2170
Diluted Average Shares
43,075.9380
36,509.0600
36,181.7530
29,848.2170
Total Operating Income as Reported
-21,439.0000
-24,822.0000
-24,539.0000
-31,684.0000
Total Expenses
21,439.0000
24,822.0000
24,539.0000
31,684.0000
Net Income from Continuing & Discontinued Operation
-17,192.0000
-24,277.0000
-24,457.0000
-31,811.0000
Normalized Income
-21,886.0000
-24,277.0000
-24,457.0000
-31,811.0000
Interest Income
--
545.0000
82.0000
--
Net Interest Income
-447.0000
545.0000
82.0000
-127.0000
EBIT
-21,439.0000
-24,822.0000
-24,539.0000
-31,684.0000
EBITDA
-21,174.0000
-24,537.0000
-24,279.0000
-31,465.0000
Reconciled Depreciation
265.0000
285.0000
260.0000
219.0000
Net Income from Continuing Operation Net Minority Interest
-17,192.0000
-24,277.0000
-24,457.0000
-31,811.0000
Total Unusual Items Excluding Goodwill
4,694.0000
--
--
--
Total Unusual Items
4,694.0000
--
--
--
Normalized EBITDA
-25,868.0000
-24,537.0000
-24,279.0000
-31,465.0000
12/31/2020 - 10/7/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BLRX BioLineRx Ltd.
0.6220
-4.88%
IMNN Imunon, Inc.
1.4800
+7.25%
GALT Galectin Therapeutics Inc.
3.0800
+1.65%
GYRE Gyre Therapeutics, Inc.
15.75
+6.28%
ENSC Ensysce Biosciences, Inc.
0.5850
+10.65%
ADIL Adial Pharmaceuticals, Inc.
1.4450
-3.67%
CNSP CNS Pharmaceuticals, Inc.
0.2040
+5.43%
CDIO Cardio Diagnostics Holdings, Inc.
0.8950
-1.13%
KTRA Kintara Therapeutics, Inc.
0.1380
-7.57%
PLX Protalix BioTherapeutics, Inc.
1.1400
+3.64%